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Abstract
Background: The Positive and Negative Affect Schedule (PANAS) is the most widely and frequently used scale to
assess positive and negative affect. The PANAS has been validated in several languages, and it has shown excellent
psychometric properties in the general population and some clinical samples, such as forensic samples, substance
users, and adult women with fibromyalgia. Nevertheless, the psychometric properties of the scale have not yet
been examined in clinical samples with anxiety, depressive, and adjustment disorders. In addition, the proliferation
of Internet-based treatments has led to the development of a wide range of assessments conducted online with
digital versions of pen and paper self-report questionnaires. However, no validations have been carried out to
analyze the psychometric properties of the online version of the PANAS. The present study investigates the
psychometric properties of the online Spanish version of the PANAS in a clinical sample of individuals with
emotional disorders.
Methods: The sample was composed of 595 Spanish adult volunteers with a diagnosis of depressive disorder (n =
237), anxiety disorder (n = 284), or adjustment disorder (n = 74). Factor structure, construct validity, internal
consistency, and sensitivity to change were analyzed.
Results: Confirmatory factor analysis yielded a latent structure of two independent factors, consistent with previous
validations of the instrument. The analyses showed adequate convergent and discriminant validity, good internal
consistency as well as sensitivity to change.
Conclusions: Overall, the results obtained in this study show that the online version of the PANAS has adequate
psychometric properties for the assessment of positive and negative affect in a Spanish clinical population.
Keywords: Positive and negative affect, Validation, Assessment, Psychometrics, Online, Emotional disorders
Introduction
The study of the structure of affect has been particularly
important in increasing psychopathological and clinical
knowledge about mental disorders. Affect plays a central
role in human experience [1], and the term has been
used to refer to anything emotional, that is, feelings,
preferences, emotions, moods, and affective traits [2, 3].
Affect is regarded as a psychological construct that refers
to mental states involving evaluative feelings (e.g., feeling
good-bad, liking-disliking a situation) [4]. Nevertheless,
the difficulty of achieving reliable measurements and the
absence of a unified model of affective processes have
limited its scientific study [5].
In recent decades, a growing number of studies have
tried to investigate the structure of affect. Most of these
studies agree that the affective experience has two dom-
inant dimensions, namely, positive affect (PA) and nega-
tive affect (NA) [6–8]. Based on the pioneering work by
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Bradburn [9], PA and NA have been described as two inde-
pendent unipolar dimensions of affect that include all the
affective states with a positive valence (joy, enthusiasm,
crush, etc.) or a negative valence (anger, fear, anxiety, etc.).
Furthermore, in a re-analysis of a large number of studies
on affect, Watson and Tellegen (1985) concluded that the
two main factors that appeared consistently were positive
and negative affect, and they presented the consensual
two-factor model. These two factors have been conceptual-
ized as two independent and uncorrelated dimensions of
affect [10]. Whereas PA reflects the “extent to which indi-
viduals feel enthusiastic, active, and alert” [11], NA involves
a variety of aversive mood states, such as anger, guilt, and
fear. The data suggest that low levels of PA are related to
and predict the onset of depression [12], and that high PA
is associated with greater well-being [13]. By contrast, low
NA indicates a state of calmness and serenity, whereas high
NA is characteristic of anxiety [11]. The two dimensions of
affect (PA and NA) have been crucial in the conceptual dif-
ferentiation between depression and anxiety disorders [14].
In addition, PA and NA have also been strongly related to
Extraversion and Neuroticism personality dimensions, re-
spectively [15].
It is important to highlight that, without an adequate
and reliable measurement of affect, it is not feasible to
conduct research that provides empirical support in this
field. Thus, the Positive and Negative Affect Schedule
(PANAS) was developed for this purpose. The PANAS is
the most widely and frequently used scale to assess PA
and NA. The original PANAS scale was designed by
Watson et al. (1988) as a brief and easy to administer
measure to assess positive and negative affect and, thus,
obtain affect descriptors that are as pure as possible. In
this regard, the authors finally isolated 10 PA markers
(PA subscale) and 10 NA markers (NA subscale), which
are the 20 items on the current version of the PANAS.
On the one hand, the PA subscale reflects the extent to
which a person feels interested, excited, strong, enthusi-
astic, proud, alert, inspired, determined, attentive, and
active. On the other hand, the NA subscale includes de-
scriptors such as stressed, upset, guilty, scared, hostile,
irritable, ashamed, nervous, jittery, and afraid. All the
items are rated on a scale ranging from 1 (“very slightly
or not at all”) to 5 (“extremely”).
Although the PANAS was initially designed and devel-
oped in North America [11], it has been validated in several
languages in both western (e.g. Italy: [16]; France and
Canada: [17]; Hungary: [18]) and non-western countries
(e.g. Turkey: [19]; Mexico: [20]; Korea: [21]; Argentina: [22];
Brasil: [23]; Africa: [24]; India: [25]; Pakistan: [26]). The re-
sults of these studies have shown excellent internal
consistency and discriminant validity. In Spain, the PANAS
has also demonstrated high internal consistency (alpha =
.89 and .91 for PA and NA in women, respectively, and
alpha = .87 and .89 for PA and NA in men, respectively) in
college students [27]. Nevertheless, the PANAS has only
been validated in the general population, both its original
version [11] and the Spanish version [27], as well as in the
other previously mentioned countries. However, some vali-
dations have been carried out with clinical samples, such as
forensic samples [28], psychiatric outpatients [21], sub-
stance users [29], and adult women with fibromyalgia [30].
Currently, the proliferation of Internet-based treatments
has led to the development of a wide range of assessments
conducted online using digital versions of pen and paper
self-report questionnaires [31, 32]. However, although
paper and online versions of the same instrument correlate
strongly, they may differ in their psychometrics properties
[31]. Therefore, the need for validated assessments admin-
istered online is increasingly evident [33], reinforcing the
importance of evidence-based assessment, that is, the use
of research and theory in the selection of assessment tar-
gets, the methods and measures used in the assessment,
and the assessment process itself [34]. Given the key role
of assessment in evidence-based practice, the development
and promotion of rigorous assessment instruments is cru-
cial for mental health researchers and clinicians. Thus, the
validation of online scales can have a direct impact on the
availability of evidence-based assessments because they can
be administered more extensively.
Although the PANAS has been validated in the general
population, the psychometric properties of this scale have
not yet been examined in clinical samples with anxiety,
depressive, and adjustment disorders. In addition, to the
best of our knowledge, no validations have been carried
out to analyze the psychometric properties of the online
version of the scale. Therefore, this is the first study to
evaluate the psychometric properties of the PANAS ad-
ministered online in a Spanish clinical population.
Current study
The present study investigates the psychometric proper-
ties of the online Spanish version of the PANAS in a
clinical sample of individuals with depressive, anxiety,
and adjustment disorders. The main objectives of this
study is the translation and validation of the scale, with
the specific objectives of: a) examining the scale’s in-
ternal consistency; b) assessing the construct validity; c)
determining the factor structure of the scale; and d) ana-
lyzing its sensitivity to change.
Method
Spanish translation of the PANAS
The goal of translation is to achieve equivalence between
the original and the translated version of the scale. The
PANAS was translated into Spanish in order to assess its
psychometric properties in this population. First, two inde-
pendent translations were developed. A native Spanish-
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speaking translator with knowledge of psychology and emo-
tional disorders translated the PANAS items from English
to Spanish. Second, a Spanish-English bilingual speaker
who was not familiar with the questionnaire translated the
instrument from Spanish to English. Then, the scale was
translated back again into the source language of the inde-
pendent translators in a “back-translation” procedure.
Finally, a committee integrated by the senior supervisors of
the study looked at the original and the back-translated
items of the scale and resolved discrepancies. The Spanish
version of the PANAS was found to be an accurate transla-
tion of the original English version (see Additional file 1 for
Spanish version of the PANAS).
Participants and procedure
Participants were recruited from patients attending the
Emotional Disorders Clinic at Universitat Jaume I (Castel-
lon, Spain). Three samples of participants who were waiting
to receive an online psychological treatment took part in the
current study. Sample 1 included participants with a diagno-
sis of anxiety and/or depressive disorder that received a
transdiagnostic Internet-based protocol for emotional disor-
ders; sample 2 included participants with a diagnosis of
adjustment disorder that participated in an Internet-based
protocol for the treatment of these disorders; and sample 3
included participants with a diagnosis of depression that re-
ceived a brief online depression protocol. A full description
of the treatments can be found elsewhere [35–37]. All the
participants were assessed with a structured diagnostic inter-
view. The interviews lasted approximately an hour and were
conducted by pre-doctoral students who had been fully
trained for this purpose. Once the inclusion criteria had
been confirmed (see “Inclusion and exclusion criteria” sec-
tion below), participants signed an online informed consent,
and the anonymity and confidentiality of the data were guar-
anteed. Before participants could access the treatment mod-
ules, their data were collected using an online battery of
questionnaires (described below in greater detail in the Mea-
sures section) administered over the Internet through a web
platform (https://www.psicologiaytecnologia.com/) designed
by our research group. Part of the sample completed the
PANAS before and immediately after receiving the Internet-
based treatment. All the research projects in which the sam-
ple participated had been approved by the Ethics Committee
at Universitat Jaume I.
Inclusion and exclusion criteria
Inclusion to the study required the presence of at least
one diagnosis of depressive, anxiety or adjustment disor-
ders. Participants also had to be 18 years or older, be flu-
ent in understanding and reading Spanish, have access
to Internet at home and an email address, and give on-
line informed consent. Participants with a severe mental
disorder (schizophrenia, bipolar disorder, and alcohol
and/or substance dependence disorder) or high risk of
suicide were excluded from the study.
Measures
Screening measures
Mini International Neuropsychiatric Interview [38].
The MINI is a short, structured, diagnostic interview for
DSM-IV and ICD- diagnoses. This interview has excellent
test-retest and inter-rater reliability (k = .88–1.00), as well
as adequate concurrent validity with the Composite Inter-
national Diagnostic Interview [39]. The Spanish validation
was used in this study [40].
Diagnostic Interview for Adjustment Disorders (Rachyla,
Botella, Mor, Tur, Lopez-Montoyo, Baños & Quero, in prep-
aration). This measure is a semi-structured interview based
on the ICD-10, DSM-IV-TR, and Structured Clinical Inter-
view for the DSM-IV (SCID-CV) for the diagnosis of anxiety
disorders. It assesses the number of stressful events in the
person’s life in the past few months and their related symp-
tomatology. This interview is currently undergoing a valid-
ation process.
Validation measures
Positive and Negative Affect Schedule-Trait (PANAS
[11];. The questionnaire contains 20 items on two sub-
scales that assess a person’s positive and negative trait
affect using a 5-point scale (1= “very slightly or not at
all”; 5=” extremely”). Both the original validation [11]
and the Spanish validation [27] showed two clearly differen-
tiated factors (PA and NA) and good psychometric proper-
ties. In the current study, Cronbach alpha was excellent for
the PANAS-P (.91) and good for the PANAS-N (.87).
Beck Depression Inventory (BDI-II [41];, using the
Spanish adaptation [42]). The questionnaire includes 21
items that assess depression severity using four response
options ranging from 0 to 3. The instrument shows
adequate internal consistency (Cronbach alpha ranging
from .76 to .96) and good test-retest reliability (0.80).
The psychometric properties of the Spanish adaptation
also show high internal consistency: Cronbach alpha of
.87 in the general population [43] and .89 in a clinical
population [44]. Cronbach alpha for the BDI-II in this
study was excellent (.91).
Beck Anxiety Inventory (BAI [45];, using the Spanish
adaptation [46]. The questionnaire contains 21 items
that assess anxiety using a four-point Likert scale. The
Spanish adaptation showed high internal consistency
(α = .93) [47]. In the present study, Cronbach alpha for
the BAI was excellent (.91).
Overall Anxiety Severity and Impairment Scale (OASIS
[48];, using the Spanish version [46]. This questionnaire
assesses the frequency and severity of anxiety through five
items rated on a 0 to 4-point scale. Cronbach alpha for the
scale was .80, and it showed good test-retest reliability (k =
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5, .82). The Spanish version of the OASIS has shown good
internal consistency (α= .86), and convergent and discrimin-
ant validity [49]. Cronbach alpha for the OASIS in the
current study was good (.87).
Patient Health Questionnaire-9 (PHQ-9 [50];. This
short 9-item questionnaire (responses ranging from 0 to
3) assesses depressive symptomatology in the previous
two weeks. Cronbach alpha for the questionnaire was
.89, and test-retest reliability was also excellent [50]. The
Spanish validation of the PHQ-9 has demonstrated a
good internal consistency in a sample of primary care
patients (α = .89) [51]. Cronbach alpha for the PHQ-9 in
this study was good (.85).
NEO-five factor Inventory [52]. The NEO FFI, the
short version of the NEO-PI-R, assesses five personality
dimensions through 60 items rated on a Likert scale ran-
ging from 0 to 4. The present study used the Neuroticism
and Extraversion scales, each containing 12 items. Internal
consistency of the Extraversion subscale was .82, and .84
for the Neuroticism scale. Test-retest reliability was .86 for
Extraversion and .89 for Neuroticism. The Spanish version
of the questionnaire also showed good properties [53]. In
the present study, Cronbach alpha was good for both the
Neuroticism (.80) and Extraversion (.86) subscales.
Data analysis
Reliability was analyzed by calculating internal consistency
(Cronbach alpha) separately with the items on the
PANAS-P and the PANAS-N.
In order to analyze the latent structure of the PANAS,
Confirmatory Factor Analysis (CFA) was performed be-
cause the PANAS has previously been validated, with a the-
oretical structure of two correlated factors repeatedly found
[54]. WLSMV (Weighted Least Square Mean and Variance
corrected) estimation was employed because the variables
did not fulfill multivariate normality, and the items were
categorical (i.e. Likert-type items). WLSMV is one of the
best estimation methods for this type of data [55, 56].
Model fit was analyzed using several indices from different
families, as recommended in the literature [57, 58]. Specific-
ally, all the indices and statistics used with WLSMV are
presented: a) chi-square; b) Comparative Fit Index (CFI);
Standardized Root Mean Residual (SRMR); and c) Root
Mean Square Error of Approximation (RMSEA). Criteria
for acceptable model fit were CFI above .90 (preferably
above .95) and RMSEA and/or SRMR below .08 [59]. CFA
was estimated with Mplus v.8 [60].
To examine construct validity, correlations between the
PANAS-P and PANAS-N and measures of anxiety (BAI,
OASIS), depression (BDI-II, PHQ-9), and temperament
(NEO-FFI) were calculated. Following Cohen’s benchmarks
[61], correlation values were interpreted as follows: effect
sizes between .10 and .30 would be considered small, be-
tween .30 and .50 would be medium, and .50 or above
would be large. A negative but medium correlation between
PANAS-P and PANAS-N was expected. A negative and
medium correlation was expected between PANAS-P and
the anxiety (BAI, OASIS) and depression measures (BDI-II,
PHQ-9). By contrast, a positive but medium correlation
was expected between PANAS-N and the anxiety and de-
pression measures. Additionally, we hypothesized positive
medium correlations between PANAS-P and the NEO-FFI-
E, and between PANAS-N and the NEO-FFI-N. Finally,
negative but medium correlations were expected between
PANAS-P and the NEO-FFI-N, and between PANAS-N
and the NEO-FFI-E. This prediction was theoretically
based on the commonalities between the affect con-
structs and the personality dimensions of neuroticism
and extraversion [62, 63].
One-way ANOVAs were performed to analyze whether
there were statistically significant differences in the scores
on the two PANAS subscales (PANAS-P and PANAS-N)
based on gender, marital status, education, principal diag-
nosis, and number of comorbid diagnoses. Correlations
between age and the PANAS subscales were calculated to
find any associations between these variables. Additionally,
reliability was analyzed by calculating internal consistency
(Cronbach alpha). These analyses were performed separ-
ately with the items on the PANAS-P and the PANAS-N.
Finally, to analyze the sensitivity of the PANAS-P and
PANAS-N scores to change, means and standard devia-
tions for the pretest and posttest were calculated for the
three samples. For each sample, minimum and maximum
PANAS-P and PANAS-N scores were obtained from the
treatment pretest and control groups to check for poten-
tial floor or ceiling effects. Evidence of floor or ceiling
effects is present when more than 15% of the participants
obtain the lowest or highest possible score on the test,
respectively (in our case, 10 and 50; cf. [64]. In addition,
for each sample, t-tests were applied to test the statistical
significance of the pretest-posttest mean differences in the
treatment group. Furthermore, to quantify the sensitivity
of the PANAS-P and PANAS-N scores to change, the
standardized mean change index was used as the effect
size, defined as the difference between the pretest and
posttest means, divided by the standard deviation of the
change scores in the treatment group:
d ¼ c mð ÞyPre−yPost=SDChange
with yPre and yPost being the pretest and posttest means
of the treatment group. The positive bias of the d index
for small sample sizes was corrected with the c(m) cor-
rection factor:
c mð Þ ¼ 1−3= 4N−5ð Þ
In addition, 95% confidence intervals for the d indices
were calculated by means of d ± 1.96xSE(d), with 1.96
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being the 97.5 percentile of the standard normal dis-
tribution, and SE(d) being the standard error of the d
index [65]:
SE dð Þ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
c mð Þ2x 1=nð Þx n−1=n−3ð Þx 1þ nd2 −d2
q
All of these calculations were applied separately for
studies 1 to 3. To offer a contextualized interpretation of
the d indices, we used the results from a systematic re-
view of meta-analyses on the efficacy of psychological
treatments, which applied the standardized mean change
index as the effect size [66]. In this review, percentiles
25, 50, and 75 of the d indices’ distribution were 0.64,
0.75, and 1.26, respectively. Therefore, a reasonable in-
terpretation of these three values is that they reflect low,
moderate, and large effect sizes.
Results
Sample description
The total sample was composed of 595 Spanish adult
volunteers (195 men; 400 women), with a mean age of
37.38 years (SD = 12.54; range: 18–76). Most of the par-
ticipants were married or living with a partner (n = 273;
45.89), and most had high-level studies (n = 352; 59.2%).
The patients had been diagnosed with depressive dis-
order (i.e. major depressive disorder, dysthymic disorder,
depression not otherwise specified) (n = 237), anxiety dis-
order (i.e. generalized anxiety disorder, panic disorder/
agoraphobia, social anxiety disorder, obsessive-compulsive
disorder) (n = 284), and adjustment disorder (n = 74). In
addition, 35% of the total sample presented at least one
comorbid anxiety or depressive disorder. Table 1 presents
a detailed description of the participants’ sociodemo-
graphic and clinical data.
Reliability
Internal consistency
Cronbach alpha was .91 for the PANAS-P and .87 for
the PANAS-N. Tables 2 and 3 display Cronbach alphas
when omitting items, corrected correlations between
each item and the total score, and correlations between
the items on PANAS-P and PANAS-N, respectively.
Convergent and divergent validity
Table 4 shows the correlations between PANAS-P and
PANAS-N and convergent and divergent validity measures.
Significant correlations were found between both PANAS-
P and PANAS-N and all the measures. As expected, a nega-
tive but medium correlation was found between PANAS-P
and PANAS-N (r = −.30, p < .01). Negative and large corre-
lations were found between PANAS-P and depression mea-
sures (BDI-II: r = −.56, p < .01; PHQ-9: r = −.52, p < .01),
whereas the correlations between PANAS-P and anxiety
measures were small to medium (BAI: r = −.23, p < .01;
Table 1 Sociodemographic and clinical characteristics of the
total sample









Education level, n (%)




Diagnosis category, n (%)
Depression 237 (39.8)
Anxiety 284 (47.7)
Adjustment disorder 74 (12.4)









Anxiety NOS 12 (2)
Depression NOS 4 (0.7)
Adjustment disorder 74 (12.4)




≥ 3 26 (4.4)









MDD Major Depressive Disorder, DD Dysthymic Disorder, GAD Generalized Anxiety
Disorder, PD/AG Panic Disorder/Agoraphobia, SAD Social Anxiety Disorder, OCD
Obsessive-Compulsive Disorder, Anxiety NOS Anxiety Not Otherwise Specified,
Depression NOS Depression Not Otherwise Specified, PANAS-P Positive and Negative
Affect Schedule - Positive Affect, PANAS-N Positive and Negative Affect Schedule -
Negative Affect, BDI-II Beck Depression Inventory, PHQ-9 Patient Health Questionnaire,
BAI Beck Anxiety Inventory, OASIS Overall Anxiety Severity and Impairment Scale, NEO-
FFI-N Neo Five-Factor Inventory - Neuroticism; NEO-FFI-E NEO Five-Factor Inventory
– Extraversion
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OASIS: r = −.39, p < .01). By contrast, positive large cor-
relations were found between PANAS-N and depres-
sion (BDI-II: r = .63, p < .01; PHQ-9: r = .54, p < .01) and
anxiety measures (BAI: r = .58, p < .01; OASIS: r = .64,
p < .01). Finally, a negative but medium correlation was
found between PANAS-P and NEO-FFI-N (r = −.39,
p < .01), and a positive and medium correlation between
PANAS-P and NEO-FFI-E (r = .44, p < .01). In addition,
a positive and large correlation was found between
PANAS-N and NEO-FFI-N (r = .65, p < .01), and a
negative but small correlation between PANAS-N and
NEO-FFI-E (r = −.24, p < .01).
Confirmatory factor analysis
The PANAS has a two-correlated factor structure, posi-
tive and negative affect. We tested this two-factor struc-
ture with a confirmatory factor analysis. The model
reasonably fitted the observed data: χ2(169) = 1425.31,
p < .001, χ2(169) = 8.43, RMSEA = .112 CI [.106–.117],
CFI = .917, TLI = .907, SRMR = .076. Fit was adequate
according to both the CFI and the SRMR. RMSEA was a
little higher than expected. However, and taking into
account that the parameter estimates were all statisti-
cally significant and very large, we can conclude that the
model has an adequate fit. Figure 1 shows the CFA
model. As mentioned above, all factor loadings were sta-
tistically significant (p < .001) and large. With regard to
the first factor (positive affect), all standardized loadings
were in the range from .68 to .85. Regarding the second
factor (negative affect), again standardized loadings were
large, with a minimum of .59 and a maximum of .83.
PANAS and sociodemographic and clinical variables
In the total sample, the mean PANAS-P score was 20.19
(SD = 6.91), and the mean PANAS-N score was 29.07
(SD = 8.14). Tables 5 and 6 show the means and




Corrected item-total correlation Item 1 Item 3 Item 5 Item 9 Item 10 Item 12 Item 14 Item 16 Item 17 Item 19
Item 1 .904 .717 1 .629 .600 .637 .463 .477 .533 .485 .477 .552
Item 3 .904 .718 1 .591 .750 .520 .444 .529 .437 .403 .556
Item 5 .902 .748 1 .658 .458 .595 .501 .498 .459 .681
Item 9 .901 .777 1 .538 .498 .586 .501 .438 .596
Item 10 .910 .606 1 .377 .492 .473 .382 .459
Item 12 .908 .645 1 .445 .467 .510 .594
Item 14 .907 .669 1 .528 .429 .515
Item 16 .908 .643 1 .489 .524
Item 17 .911 .593 1 .496
Item 19 .903 .735 1
All correlations were statistically significant at p < .01 (two-tailed); Item 1: Interested; Item 3: Excited; Item 5: Strong; Item 9: Enthusiastic; Item 10: Proud; Item 12:
Alert; Item 14: Inspired; Item 16: Determined; Item 17: Attentive; Item 19: Active




Corrected item-total correlation Item 2 Item 4 Item 6 Item 7 Item 8 Item 11 Item 13 Item 15 Item 18 Item 20
Item 2 .858 .576 1 .467 .318 .339 .368 .471 .243 .588 .528 .305
Item 4 .855 .607 1 .386 .354 .517 .612 .330 .391 .406 .317
Item 6 .860 .554 1 .452 .363 .333 .536 .353 .359 .311
Item 7 .852 .641 1 .308 .271 .428 .462 .461 .769
Item 8 .860 .545 1 .660 .279 .322 .324 .273
Item 11 .857 .574 1 .276 .398 .361 .259
Item 13 .863 .517 1 .331 .317 .423
Item 15 .853 .641 1 .686 .437
Item 18 .853 .640 1 .504
Item 20 .857 .591 1
All correlations were statistically significant at p < .01 (two-tailed); Item 2: Distressed; Item 4: Upset; Item 6: Guilty; Item 7: Scared; Item 8: Hostile; Item 11: Irritable;
Item 13: Ashamed; Item 15: Nervous; Item 18: Jittery; Item 20: Afraid
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standard deviations for each item and the total score on
both the PANAS-P and the PANAS-N by diagnosis
category.
On the PANAS-P, the results of one-way ANOVAs
yielded statistically significant differences based on civil sta-
tus, F(3, 591) = 3.05, p < .05, diagnostic category, F(2,
592) = 12.22, p < .001, principal diagnosis, F(10, 584) = 5.56,
p < .001, and number of comorbid diagnoses, F(3, 590) =
2.92, p < .05. Sidak’s post hoc tests showed that patients in
the category of depressive disorders had significantly lower
scores on PA than those in the categories of anxiety
(p < .001) and adjustment disorders (p < .05). Additionally,
the results of Sidak’s post hoc tests showed that patients
with MDD as the principal diagnosis had significantly
lower scores on PA than patients with GAD (p < .01), AG
(p < .01) and OCD (p < .001). On the PANAS-N, no signifi-
cant differences were found on any of the sociodemo-
graphic or clinical variables, except for the number of
comorbid diagnoses, F(3, 590) = 9.07, p < .001). Sidak’s post
hoc tests showed that patients with one (p < .01), two
(p < .05) or three (p < .01) comorbid disorders had signifi-
cantly higher scores on NA, compared to patients with no
comorbid diagnoses.
Sensitivity to change
To examine potential floor and ceiling effects for the
PANAS-P and PANAS-N scores, the frequencies and
percentages of minimum (10) and maximum (50) scores
on the pretest were tabulated for each sample, using the
participants in the treatment and control groups. As
Table 7 shows, floor and ceiling effects can be ruled out
because the percentage of minimum and maximum
scores was less than 15% in all three studies.
In addition, means and standard deviations for the
pretest and posttest were calculated for the treatment
groups in each sample. The statistical significance of the
pretest-posttest change scores was assessed by applying
t-tests. As Table 8 shows, statistically significant pretest-
posttest differences were found in the three studies for
both PANAS-P and PANAS-N scores. Clinical signifi-
cance was assessed by means of the effect size index
‘standardized mean change index’ (d). Following Rubio-
Aparicio et al.’s (2017) results, with the exception of the
PANAS-P scores in Sample 3, all effect sizes were mod-
erate to large (all over 0.74).
Discussion
The present study was designed to evaluate the psycho-
metric properties of the PANAS scale in a Spanish clinical
sample with anxiety, depressive, and adjustment disorders.
In addition, its objective was to validate the scale adminis-
tered in an online format, thus contributing to the use of
evidence-based assessment. At the same time, the current
study investigated the factorial validity of the Spanish ver-
sion of the PANAS using confirmatory factor analyses.
Preliminary analyses showed no statistically significant
differences based on gender, education level, or marital
status. However, statistically significant differences were
found depending on the principal diagnosis, showing
that patients with depression had lower levels of PA than
patients with anxiety and adjustment disorders. No dif-
ferences in NA were found based on the principal diag-
nosis. These results are consistent with the literature,
indicating that low levels of PA predict the onset of
depression [12], reduce positive emotions, and increase
the severity of the depressive symptoms [67]. In fact, the
literature shows that depressive symptoms often involve
low levels of positive emotions, and that low levels of
positive affect are more strongly linked to depression
than to other emotional disorders [63, 68, 69].
Furthermore, regarding the number of comorbid dis-
orders, 35% of the total sample presented at least one
comorbid anxiety or depressive disorder. The results re-
veal that patients with more comorbid diagnoses had
significantly higher NA and lower PA than patients with
fewer comorbid disorders, which coincides with evidence
showing that severity is strongly related to comorbidity
[70]. For reliability, it is generally accepted that alpha
Table 4 Correlations of PANAS-P and PANAS-N with convergent and divergent validity measures
PANAS-P PANAS-N BDI-II PHQ-9 BAI OASIS NEO-FFI-N NEO-FFI-E
PANAS-P 1 −.30 −.56 −.52 −.23 −.39 −.39 .44
PANAS-N 1 .63 .54 .58 .64 .65 −.24
BDI-II 1 .83 .51 .66 .64 −.28
PHQ-9 1 .52 .63 .60 −.25
BAI 1 .63 .48 −.17
OASIS 1 .51 −.26
NEO-FFI-N 1 −.30
NEO-FFI-E 1
All correlations were statistically significant at p < .01 (two-tailed). PANAS-P Positive and Negative Affect Schedule - Positive Affect, PANAS-N Positive and Negative
Affect Schedule - Negative Affect, BDI-II Beck Depression Inventory, PHQ-9 Patient Health Questionnaire, BAI Beck Anxiety Inventory, OASIS Overall Anxiety Severity
and Impairment Scale, NEO-FFI-N Neo Five-Factor Inventory – Neuroticism, NEO-FFI-E NEO Five-Factor Inventory – Extraversion
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coefficients must be over .70 for exploratory research, over
.80 for general research purposes, and over .90 when the
test is used for clinical decisions [71]. In addition, Cicchetti
(1994) [72] suggested the following guidelines for assessing
the clinical relevance of alpha coefficients: unacceptable for
coefficients lower than .7, fair for the .7–.8 range, good for
the .8–.9 range, and excellent for values over .9. There-
fore, according to these criteria, both PANAS-P and
PANAS-N exhibited good to excellent internal consistency
reliability (alphas of .91 and .87, respectively).
Regarding construct validity, convergent and divergent
validity were demonstrated by correlations between
PANAS-P and PANAS-N and depression, anxiety, and
personality measures. Overall, significant correlations
were found between positive and negative affect and all
the measures. Convergent and discriminant validity were
supported because NA scores were strongly correlated
with symptoms of depression (measured by the BDI-II
and PHQ-9) and anxiety (measured by the BAI and
OASIS), whereas PA showed strong inverse correlations
Fig. 1 Confirmatory factor analysis (CFA) model. Note. Rectangles are measured variables, the large circles are the latent construct, and ellipses
are residual variances. Factor loadings are standardized
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with depression measures and small to medium correla-
tions with anxiety measures. Finally, as expected,
PANAS-P correlated significantly with NEO-FFI-E and
negatively with NEO-FFI-N. At the same time, PANAS-
N correlated significantly with NEO-FFI-N, and inversely
with NEO-FFI-E. Although the small correlation found
between PANAS-N and NEO-FFI-E might stand out,
this result is theoretically expected due to the common-
alities shown between the affectivity and temperament
dimensions of neuroticism and extraversion. The pres-
ence of high levels of neuroticism has been related to ex-
periences of NA, whereas PA has traditionally been
more related to the extraversion dimension [62, 63].
This study also examined the latent structure of the
PANAS, and Confirmatory Factor Analysis was per-
formed. The confirmatory factor analysis yielded a latent
structure of two independent factors, coinciding with
previous validations of the instrument and with the the-
oretical framework of positive and negative affect that
conceptualizes them as two independent temperamental
dimensions [9, 10, 15].
Regarding sensitivity to change, this study also analyzed
the significance of the improvements from pre- to post-
treatment on the PANAS scores. The results showed
statistically significant pretest-posttest differences in the
three studies for both PANAS-P and PANAS-N, with
moderate to large effect sizes, suggesting that the scale is
able to detect changes in affectivity and, therefore, can be
used to examine the impact of an intervention.
Overall, the results obtained in this study show ad-
equate psychometric properties for the online version of
the PANAS as a measure for the assessment of positive








M SD M SD M SD
Item 1 2.24 .94 2.54 1.01 2.51 .98
Item 3 1.77 .85 2.19 .99 2.08 1.02
Item 5 1.80 .83 2.07 .92 1.93 .93
Item 9 1.56 .74 1.98 .89 1.89 .99
Item 10 1.74 .88 2.00 .94 2.00 .91
Item 12 2.00 .81 2.15 .87 2.11 1.00
Item 14 1.71 .81 1.94 .90 1.93 1.03
Item 16 1.78 .87 1.97 .93 2.14 1.09
Item 17 1.94 .86 2.05 .86 2.01 .99
Item 19 1.98 .90 2.30 .98 2.34 1.19
Total score 18.51 6.06 21.40 7.07 20.95 7.78
Item 1: Interested; Item 3: Excited; Item 5: Strong; Item 9: Enthusiastic; Item 10:
Proud; Item 12: Alert; Item 14: Inspired; Item 16: Determined; Item 17:
Attentive; Item 19: Active








M SD M SD M SD
Item 2 3.47 1.04 3.61 1.06 3.68 1.09
Item 4 3.03 1.15 2.93 1.12 2.96 1.08
Item 6 2.87 1.39 2.63 1.27 2.78 1.39
Item 7 2.70 1.29 2.92 1.31 2.62 1.29
Item 8 2.28 1.08 2.19 1.09 2.36 1.14
Item 11 2.90 1.20 2.80 1.20 2.72 1.14
Item 13 2.24 1.27 2.41 1.32 2.32 1.32
Item 15 3.35 1.12 3.57 1.12 3.30 1.08
Item 18 3.28 1.12 3.43 1.11 3.24 1.02
Item 20 2.81 1.39 3.11 1.34 2.68 1.34
Total score 28.92 8.06 29.31 8.32 28.66 7.75
Item 2: Distressed; Item 4: Upset; Item 6: Guilty; Item 7: Scared; Item 8: Hostile; Item
11: Irritable; Item 13: Ashamed; Item 15: Nervous; Item 18: Jittery; Item 20: Afraid
Table 7 Frequency (and %) of minimum (10) and maximum
(50) scores on the pretest in the three studies
Sample N Minimum (10) Maximum (50)
S1:
PANAS-P 207 4(1.9%) 0(0%)
PANAS-N 207 0(0%) 1(0.5%)
S2:
PANAS-P 35 2(5.7%) 0(0%)
PANAS-N 35 0(0%) 0(0%)
S3:
PANAS-P 125 4(3.2%) 0(0%)
PANAS-N 125 0(0%) 0(0%)
S sample, N sample size, PANAS-P Positive and Negative Affect Schedule -
Positive Affect, PANAS-N Positive and Negative Affect Schedule -
Negative Affect
Table 8 Descriptive and inferential results from the three
samples for the PANAS on the pre-posttest scores
Sample N Pretest Posttest t d[95% CI]
Mean SD Mean SD
S1:
PANAS-P 136 20.51 6.90 26.42 9.10 8.62*** 0.74[0.54; 0.93]
PANAS-N 136 31.24 8.17 21.01 8.28 14.20*** 1.21[0.99; 1.43]
S2:
PANAS-P 16 20.00 8.97 32.00 8.45 5.74*** 1.36[0.63; 2.09]
PANAS-N 16 30.44 8.14 20.69 6.60 4.21*** 1.00[0.37; 1.63]
S3:
PANAS-P 105 19.12 6.16 23.64 8.45 6.32*** 0.61[0.40; 0.82]
PANAS-N 105 27.99 8.47 21.75 8.65 8.04*** 0.78[0.56; 1.00]
S sample, N sample size, SD standard deviation; T: t statistic for testing the
pretest-posttest mean difference; *** p < .001. d: standardized mean change
index (95%CI)
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and negative affect in a Spanish clinical population.
These results reinforce the importance of validating on-
line assessment instruments, given the current prolifera-
tion of Internet-based psychological treatments.
The present study has several strengths. First, to our
knowledge, this is the first study to evaluate the psycho-
metric properties of the PANAS in a Spanish clinical
population. Second, this is the first validation of this
instrument in an online format. The literature presents
considerable evidence about the efficacy of Internet-based
interventions for emotional disorders [73, 74]. Recently in
our country, studies have been carried out that also guar-
antee their efficacy [75–77], and so it is important to have
validated online assessment tools that can be used to as-
sess PA and NA (two core symptoms) in research and
clinical settings. In this regard, the present study provides
empirical evidence about the usefulness of the instrument
in distinguishing between PA and NA with a digital ver-
sion of the questionnaire. Furthermore, online assessment
also has advantages in clinical practice and routine care,
where there are always time limitations. In this way, it is
possible to reach more people in less time than with paper
and pencil evaluations. Research results encourage the use
of online questionnaires because they offer many advan-
tages over traditional data collection methods [78–80].
For instance, missing data can be handled in a more
straightforward way, and scoring is easy and immediate
[78]. In addition, online assessment allows users to receive
feedback about their progress [81]. Finally, the high diag-
nostic heterogeneity in the present study (i.e. individuals
with anxiety, depressive, and adjustment disorders) helps
to increase the generalizability of the results.
Limitations
This study has several limitations that should be men-
tioned. First, it was not possible to calculate sensitivity to
change with the whole sample because post-treatment
scores were not available for all the participants in this
study. Second, the validation was limited to participants
with psychological disorders. Therefore, we were not able
to obtain cutoff scores on the PANAS. Finally, we did not
evaluate the test-retest reliability of the PANAS. Literature
has shown that there is a wide variety of administration
intervals used in test-retest reliability [82]. However, the
length of the test-retest interval can affect patient’s
responses and should be sufficiently long to ensure that
patients do not remember their previous answer, though
sufficiently short to ensure that clinical change has not oc-
curred over time [83]. The most common period that has
been stablished as appropriate is 1 or 2 weeks [83]. In this
study, due to the long time interval between the two
measurement times (pretest-posttest) in each clinical sam-
ples (sample 1: 16 weeks; sample 2: 7 weeks; sample 3: 4
weeks) and the knowledge that results could have been
contaminated over time, we decided not to evaluate the
test-retest reliability.
Conclusion
In conclusion, the results of this study support the ad-
equacy of the PANAS applied online in Spanish clinical
samples suffering from different mental disorders (i.e. anx-
ious, depressive, and adjustment disorders). Overall, the
present study provides a psychometrically-validated online
measure to assess the structure of affect, and it supports
the application of the PANAS in clinical settings. Future
research should analyze the validity and reliability of the
PANAS in more severe patients (e.g., bipolar or psychotic
disorders). This online validation can have a direct impact
on evidence-based assessment, facilitating access to appro-
priate instruments for evaluating affectivity in mental
disorders.
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